Cord Stem Cell Banking is the concept which is used to preserve the stem cell for the future use at the time of emergencies. Cryopreservation is a system when stem cells are preserved much below freezing degree temperature. Umbilical cord blood (UCB) is collected from new born baby and it is enriched with adult stem cells it can also be restored from the placenta after the delivery. Stem Cell play very important role in developing tissues in human body and balance the biological activities. Cord stem cell banking demand would increase in coming years due to increasing in the awareness and knowledge about storage of cord blood and tissue stem cell for medical use for the treatment of diabetes, heart diseases, cancer, Parkinson’s disease and others.
How Big is The Global Cord Stem Cell Banking Market?
The Global Cord Stem Cell Banking Market is expected to be around US$ 10.90 Billion by 2028 at a CAGR of 20.2% in the given forecast period.
The major driving factors of Global Cord Stem Cell Banking Market are as follows:
The restraining factors of Global Cord Stem Cell Banking Market are as follows:
The Global Cord Stem Cell Banking Market is segmented on the lines of its Type, Services, application and regional. Based on type it covers cord blood and cord tissues. And Services is segmented into collection and transportation, processing, analysis and storage. Whereas application includes cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes and Others. The Global Cord Stem Cell Banking Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Cord Stem cell banking and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Cord stem cell banking.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of global and regional markets Global Cord Stem Cell Banking Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report includeChina Cord Blood Corporation (China), Cryo-Cell International (U.S.), ViaCord (By Perkin Elmer) (U.S.),StemCyte (U.S.), Cord Blood Registry (U.S.), Smart Cells (U.K.), Cryo-Save (Netherlands), Cryoviva (India), LifeCell (India), Cordlife (Singapore) and Cordvida (Brazil). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Cord Stem Cell Banking Market has been segmented as below:
By Type Analysis:
By Service Analysis:
By Application Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Stem Cell banking Market
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Stem Cell banking market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Single-Use Equipment for Biopharmaceutical market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Key Data From Secondary Sources
2.1.2 Key Data From Primary Sources
2.1.2.1 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.4.1 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Attractive Opportunities in the Stem Cell Banking Market
5 Market Overview
5.1 Market Segmentation
5.1.1 Stem Cell Banking, By Bank Type
5.1.2 Stem Cell Banking, By Service
5.1.3 Stem Cell Banking, By Application
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Easy Extraction Methods
5.2.1.2 Rising Number of Newborns
5.2.1.3 Growth in Gdp, Disposable Income, and Increased Awareness of Stem Cell Therapeutics
5.2.1.4 Potential of Stem Cells in Disease Treatment
5.2.2 Restraints
5.2.2.1 High Competition in the Stem Cell Banking Market
5.2.2.2 High Operating Cost
5.2.2.3 Lack of Acceptance
5.2.2.4 Changes in Legal Regulations
5.2.3 Opportunities
5.2.3.1 Rising Awareness About Potential Use of Cord Tissue
5.2.3.2 Collaborations Among Cord Blood Banks
5.2.3.3 The Automation of Procedures
5.2.4 Challenges
5.2.4.1 Entry Barriers in the Market
6 Stem Cell Banking Market, By Bank Type
6.1 Introduction
6.2 Cord Blood
6.3 Cord Tissue
7 Market By Service
7.1 Introduction
7.2 Collection & Transportation
7.3 Processing
7.4 Analysis
7.5 Storage
8 Stem Cell Banking Market, By Application
8.1 Introduction
8.2 Cerebral Palsy
8.3 Thalassemia
8.4 Leukemia
8.5 Diabetes
8.6 Autism
8.7 Others
9 Stem Cell Banking Market, By Region
9.1 Introduction
9.2 North America
9.2.1 North America, By Country
9.2.2 North America, By Type
9.2.3 North America, By Service
9.2.4 North America, By Application
9.3 Europe
9.3.1 Europe, By Country
9.3.2 Europe, By Type
9.3.3 Europe, By Service
9.3.4 Europe, By Application
9.4 Asia-Pacific
9.4.1 Asia-Pacific, By Country
9.4.2 Asia-Pacific, By Type
9.4.3 Asia-Pacific, By Service
9.4.4 Asia-Pacific, By Application
9.5 Rest of The World (RoW)
9.5.1 Rest of the World, By Type
9.5.2 Rest of the World, By Service
9.5.3 Rest of the World, By Application
10 Competitive Landscape
10.1 Company Share Analysis
10.2 New Service/Product Launches
10.3 Mergers & Acquisitions
10.4 Regulatory Approvals
10.5 Partnerships
10.6 Joint Venture
10.7 Agreements
10.8 Collaborations
10.9 Technological Update
10.10 Patent
10.11 Geographical Expansion
10.12 Others
11 Company Profile
11.1 CBR Systems, Inc.
11.2 Cordlife
11.3 Cryo-Cell
11.4 Cryo-Save AG (A Group of Esperite)
11.5 Lifecell
11.6 Stemcyte
11.7 Viacord
11.8 Smart Cells International Ltd.
11.9 Cryoviva India
11.10 Cordvida
11.11 China Cord Blood Corporation
The Global Cord Stem Cell Banking Market has been segmented as below:
By Type Analysis:
By Service Analysis:
By Application Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
